Mr. Wolf is a partner and co-chair of the firm's Intellectual Property practice group. He is also a member of the Litigation practice group and has been lead trial counsel in some of the most significant cases brought by and against global technology companies. His professional activities focus on patent, trade secret, licensing, and business tort issues, particularly involving medical and biomedical technologies and computer hardware, software, and networking. While much of Mr. Wolf's practice is in federal trial courts throughout the United States, he also has extensive arbitration, appellate, and counseling/diligence experience.
Mr. Wolf has been recognized as a "key individual" for his achievements in patent litigation in Chambers USA (2012), and Chambers USA (2011) states that he "is heralded as 'a great legal strategist and a compelling courtroom attorney - he has an outstanding sense of urgency.'" Mr. Wolf was also named to the National Panel in IAM's Patent Litigation 250: The World's Leading Patent Litigators 2011. Prior to attending the University of Virginia School of Law, Mr. Wolf was World University Debate Champion in 1990.
Intellectual Property Representative Matters
Representative Trials and Arbitrations
- JNJ/Wyeth v. Boston Scientific (1). Invalidated all four patents-in-suit in a multibillion dollar dispute over market leading drug-coated stents.
- JNJ/Wyeth v. Boston Scientific (2). Invalidated both patents-in-suit concerning purportedly pioneering anti-proliferative drug.
- In defending a series of patent and trade secret suits and arbitrations, obtained walk-away settlement for manufacturer of miniature electronic amplifiers and pulse-width control systems.
- Hologic v. IZI. Obtained infringement verdict and subsequent permanent injunction in suit involving accessories for mammography units.
- Inflow v. Boston Scientific Corp. Won complete defense victory against an infringement claim for US$105 million involving medical device architecture patents.
- [Confidential Arbitration Claimant] v.Hologic. Defeated claim in excess of US$25 million for expansion of royalty base and term in biomedical technology license.
- Freedom Wireless, Inc. v. Verizon Wireless. Represented only victorious defendant in multi-defendant suit involving patents on telecommunications systems and equipment.
- BioMedino v. GE Healthcare. Secured summary judgment of patent invalidity against claim for US$40 million in matter involving liquid chromatography.
- Boston Scientific v. Cook/Guidant. Secured permanent injunction valued at US$5 billion precluding early entry into drug eluting stent market.
- Medical Monitoring and Paging LLC v.General Electric Company. In a suit involving telecommunications and paging patents, secured freedom to operate for a fraction of expected trial costs following summary judgment and re-examination proceedings.
- GE Healthcare v. ABI. Won judgment in excess of US$30 million in technology license dispute.
- Jang v. Boston Scientific Corp. (1). Secured summary judgment against a patent infringement claim for over US$125 million.
- Jang v. Boston Scientific Corp.(2). Defeated breach of contract claim seeking US$100 million.
- Boston Scientific v. Medtronic. Won judgment in excess of US$160 million and secured injunction against future infringing sales of catheter systems.
- Judicial Comment. Hon T. John Ward (ED Tex.) to the jury in Medtronic v. Boston Scientific (opposing counsel McKool Smith): "You've had an unusual experience in my nine years on the bench. I have never seen a case better tried by either side. So, the lawyers are to be complimented for the way they conducted themselves."
- Judicial Comment. Hon. Ronald M. Whyte (ND Cal.) to parties in Hologic v. SenoRx (opposing counsel Williams & Connolly): "I've tried a number of patent cases and this was a real pleasure. I thought this was the most professionally handled case from both sides that I've seen and it sure made it a lot easier for me, and I appreciate it."
Representative Appellate Work
- JNJ/Wyeth v. Boston Scientific. Won CAFC affirmance of judgment invalidating patents-in-suit in a multibillion dollar dispute over market-leading drug-coated stents.
- Hologic v. SenoRx. Secured CAFC vacatur of invalidity ruling following trial judgment that radiation treatment patents were infringed but invalid.
- Bonzel v. Boston Scientific. Won CAFC affirmance of estoppel-based dismissal of patent license dispute.
Representative Diligence and Counseling Activity
- Leading diligence teams, including analyzing acquisition-related intellectual property risks.
- Counseling on a range of technology/intellectual property issues, e.g., evaluating in-licensing and out-licensing strategies and implementation, developing strategies for protecting products facing imminent expiration of intellectual property rights, and analyzing client and competitor strategic portfolios pursuant to the development of long-term intellectual property enforcement and product defense plans.
Chambers USA: America's Leading Lawyers for Business 2012 for Intellectual Property: Litigation
Named to IAM Patent 1000 - The World's Leading Patent Practitioners 2012 for Litigation
Named to IAM Patent Litigation 250: The World’s Leading Patent Litigators 2011 (National and DC Panels)
Chambers USA: America's Leading Lawyers for Business 2011-2012 for Intellectual Property